Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling
新型混合分子通过抑制 JAK1-STAT3-BCL2 信号传导克服了实体肿瘤对 HDAC 抑制剂的有限反应
期刊:Theranostics
影响因子:12.4
doi:10.7150/thno.26627
Zhi Huang, Wei Zhou, Yongtao Li, Mei Cao, Tianqi Wang, Yakun Ma, Qingxiang Guo, Xin Wang, Chao Zhang, Chenglan Zhang, Wenzhi Shen, Yanhua Liu, Yanan Chen, Jianyu Zheng, Shengyong Yang, Yan Fan, Rong Xiang